Global Molluscum Contagiosum (MC) Treatment Industry is projected to maintain a 5% CAGR till 2033, based on FMI’s evaluation

Molluscum Contagiosum (MC) Treatment Industry

The global molluscum contagiosum (MC) treatment industry size is expected to grow significantly from 2018 to 2022, with a continued upward trajectory in demand from 2023 to 2033. Factors such as increasing prevalence of MC, growing awareness and diagnosis rates, availability of advanced treatment options, and high healthcare expenditure are expected to drive market growth during this period. According to a new market research report published by Future Market insights, the global Molluscum Contagiosum (MC) Treatment market is expected to garner a market value of US$ 3 Billion in 2023, and is expected to grow at a CAGR of 5% from 2023 to 2033, reaching a market size of US$ 4.89 Billion by 2033.

The report highlights that the prevalence of MC is increasing worldwide, with a growing number of cases being reported each year. This is driving the demand for MC treatment, which is expected to continue to rise in the coming years. The report also notes that there is a growing awareness of MC among the general population, leading to more people seeking medical attention for the infection.

Request A Sample Copy of This Report! https://www.futuremarketinsights.com/reports/sample/rep-gb-16795

The availability of advanced treatment options is another key factor driving the growth of the MC treatment market. The report highlights that there are a range of treatment options available for MC, including topical creams, cryotherapy, and laser therapy. Key players in the market are investing in research and development to develop new and advanced treatment options, which is driving market growth.

Key Takeaways from the Market Study:

• From 2018 to 2022, the Molluscum Contagiosum (MC) Treatment market grew at a CAGR of 3.5%.
• The global Molluscum Contagiosum (MC) Treatment market is expected to grow with a 5% CAGR during 2023 to 2033.
• As of 2033, the Molluscum Contagiosum (MC) Treatment Market is expected to reach US$ 4.89 Billion.
• According to the FMI analysis, surgical treatment accounts for the largest market share.
• North America is expected to possess 40% market share for the Molluscum Contagiosum (MC) Treatment market.
• The East & South Asia market is predicted to increase significantly throughout the forecast period, with a share of 20% during the forecast period.

“A series of international level collaborations involving healthcare stakeholders across various institutional settings are fueling further clinical trials and research studies dedicated to discovering Molluscum Contagiosum (MC) Treatment.” says an FMI analyst

Our Analyst Is Available To Help You With Any Inquiries You May Have! https://www.futuremarketinsights.com/ask-question/rep-gb-16795

Market Competition:

Key players in the market include companies such as Competition Deep Dive, Novan, Inc., Veloce Biopharma, Gurina Foundation, Azafaros, Polaryx Therapeutics, Abbott Medtronic, Merck & Co., Inc., Pfizer Inc., Siemens Healthcare GmbH, Novartis AG, along with healthcare providers and technology companies among other global players.

• In January 2023, Novan, Inc. announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) seeking approval for berdazimer gel, 10.3% (SB206) for the treatment of molluscum contagiosum. The filing is expected to be reviewed within a typical 12-month period, with a potential approval date in the first quarter of 2024 if accepted. Results from the pivotal Phase 3 B-SIMPLE4 clinical study evaluating berdazimer gel, 10.3% were highly statistically significant and demonstrated improvement in primary clinical endpoint, and the product was found to be well tolerated with mild adverse events reported.

More Insights Available:

FMI, in its new offering, presents an unbiased analysis of the global Molluscum Contagiosum (MC) Treatment market, presenting historical analysis from 2018 to 2022 and forecast statistics for the period of 2023 to 2033.

The study reveals essential insights on the basis of type, treatment, end-user & Region.

Ignite Innovation with Customization: Uncover the Possibilities in Our Report! https://www.futuremarketinsights.com/customization-available/rep-gb-16795

Key Segments Profiled in the Molluscum Contagiosum (MC) Treatment Industry Survey:

Therapy:

• Cryotherapy
• Curettage
• Immune-modulating Therapies
• Topical Therapies

End-User:

• Hospital
• Skin Clinics
• Immunocompromised Patients

Region:

• North America
• Latin America
• Europe
• East Asia
• South Asia
• Oceania
• Middle East & Africa

Author By:

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Nandini Singh Sawlani   

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube